SIM-VIVO LLC — Department of Defense SBIR Phase II: DHP16-011
SIM-VIVO LLC — SBIR Phase II award from Department of Defense.
Summary
SIM-VIVO LLC received $1.22 million from the Defense Health Agency to develop a steerable chest tube with an integrated infusion cannula. The device is designed to prevent retained hemothorax after traumatic injury.
- Amount
- $1,220,951
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- SBIR · Phase II
- Topic
- DHP16-011
- Solicitation
- 16.1
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- FL
- Period
- 2023-08-28 → 2026-12-27
Technology domains
Description
SIM*VIVO DHA SBIR SEQUENTIAL PHASE II H2S-0043 STEERABLE CHEST TUBE WITH INTEGRATED INFUSION CANNULA FOR THE PREVENTION OF RETAINED HEMOTHORAX AFTER INJURY